Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Combined Inspiratory Muscle and 'Whole Muscle' Training in Children With Cystic Fibrosis

This study has been completed.
Hospital Infantil Universitario Niño Jesús, Madrid, Spain
Information provided by (Responsible Party):
Alejandro Lucia, Universidad Europea de Madrid Identifier:
First received: October 9, 2012
Last updated: October 11, 2012
Last verified: October 2012
To study the effects of an 8-week combined inspiratory muscle training and exercise (resistance+aerobic) program on of a lung volume, inspiratory muscle strength (maximal inspiratory pressure, PImax) and cardiorespiratory fitness (maximal oxygen uptake, VO2peak) (primary outcomes)and dynamic muscle strength, body composition and quality of life (QoL) in children with Cystic Fibrosis (CF) (secondary outcomes).

Condition Intervention
Cystic Fibrosis
Other: Other

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind (Outcomes Assessor)

Resource links provided by NLM:

Further study details as provided by Universidad Europea de Madrid:

Primary Outcome Measures:
  • cardiorespiratory fitness (VO2peak) [ Time Frame: this outcome will be assessed up to 12 weeks ]
    maximum oxygen uptake (VO2peak), which is the best indicator of aerobic fitness in humans and an independent mortality predictor in children with cystic fibrosis

Secondary Outcome Measures:
  • quality of life [ Time Frame: this outcome will be assessed up to 12 weeks ]
    children's QoL with the Spanish Version (1.0) of the Cystic Fibrosis Questionnaire-Revised (CFQ-R).

Other Outcome Measures:
  • Maximal inspiratory pressure (PImax) [ Time Frame: september 2011-july 2012 ]
    an indicator of the strength of inspiratory muscles

Enrollment: 20
Study Start Date: September 2011
Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control
Exercise training
Other: Other
inspiratory muscle training (IMT) + aerobic and strength training 8-week duration IMT twice a day (mostly at home) + 3 weekly sessions of inhospital resistance + aerobic training
Other Name: Exercise training

Detailed Description:
The investigators hypothesized that the combined training program would significantly benefit most of the aforementioned variables (especially, primary outcomes).

Ages Eligible for Study:   6 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • boy/girl aged 6-17 years
  • living in the Madrid area

Exclusion Criteria:

  • severe lung deterioration [forced expiratory volume (FEV1) <50% of expected]
  • unstable clinical condition (hospitalization within the previous 3 months)
  • Burkholderia cepacia infection
  • any disorder (e.g. muscle-skeletal) impairing exercise.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01706445

Hospital Infantil Universitario Niño Jesús
Madrid, Spain
Sponsors and Collaborators
Universidad Europea de Madrid
Hospital Infantil Universitario Niño Jesús, Madrid, Spain
  More Information

Responsible Party: Alejandro Lucia, MD PhD, Universidad Europea de Madrid Identifier: NCT01706445     History of Changes
Other Study ID Numbers: kid'strainingCF
CFtraining ( Registry Identifier: PS09/00194 )
Study First Received: October 9, 2012
Last Updated: October 11, 2012

Keywords provided by Universidad Europea de Madrid:
cystic fibrosis
cardiorespiratory fitness
muscle strength
pulmonary function
quality of life

Additional relevant MeSH terms:
Cystic Fibrosis
Pathologic Processes
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases processed this record on April 28, 2017